RPHM Old News

RPHMDelisted Stock  USD 18.20  1.40  8.33%   
About 55% of RPHM Old's investors are presently thinking to get in. The analysis of current outlook of investing in RPHM Old suggests that some traders are interested regarding RPHM Old's prospects. RPHM Old's investing sentiment overview a quick insight into current market opportunities from investing in RPHM Old. Many technical investors use RPHM Old stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
over three months ago at globenewswire.com         
OnKure Announces Closing of Merger with Reneo Pharmaceuticals and Concurrent Private Placement of 65...
Macroaxis News: globenewswire.com
over three months ago at globenewswire.com         
OnKure Announces Closing of Merger with Reneo Pharmaceuticals and Concurrent Private Placement of 65...
Macroaxis News: globenewswire.com
over three months ago at globenewswire.com         
Reneo Pharmaceuticals Announces Stockholder Approval of Merger with OnKure
Macroaxis News: globenewswire.com
over three months ago at seekingalpha.com         
Reneo stockholders approve merger with OnKure
seekingalpha News
over three months ago at thelincolnianonline.com         
Insider Buying Reneo Pharmaceuticals, Inc. Major Shareholder Acquires 41,736.00 in Stock
news
over three months ago at investing.com         
Reneo Pharmaceuticals executive buys shares worth over 144k
Investing News at Macroaxis
over three months ago at www.macroaxis.com         
Acquisition by Leonard Braden Michael of 68746 shares of Reneo Pharmaceuticals at 1.4964 subject to ...
Macroaxis News
over three months ago at www.macroaxis.com         
Acquisition by Leonard Braden Michael of 29600 shares of Reneo Pharmaceuticals at 1.4144 subject to ...
Macroaxis News
over three months ago at www.macroaxis.com         
Acquisition by Gregory Flesher of 300000 shares of Reneo Pharmaceuticals subject to Rule 16b-3
Macroaxis News
over three months ago at investing.com         
Reneo Pharmaceuticals executive buys over 76k in company stock
Investing News at Macroaxis
over three months ago at www.macroaxis.com         
Acquisition by Leonard Braden Michael of 806 shares of Reneo Pharmaceuticals at 1.4 subject to Rule ...
Macroaxis News
over three months ago at www.macroaxis.com         
Acquisition by Leonard Braden Michael of 55300 shares of Reneo Pharmaceuticals at 1.3582 subject to ...
Macroaxis News
over three months ago at www.macroaxis.com         
Acquisition by Leonard Braden Michael of 172747 shares of Reneo Pharmaceuticals at 1.3712 subject to...
Macroaxis News
over three months ago at www.macroaxis.com         
Acquisition by Leonard Braden Michael of 150000 shares of Reneo Pharmaceuticals at 1.313 subject to ...
Macroaxis News
over three months ago at www.macroaxis.com         
Acquisition by Leonard Braden Michael of 36176 shares of Reneo Pharmaceuticals at 1.3966 subject to ...
Macroaxis News
Far too much social signal, news, headlines, and media speculation about RPHM Old that are available to investors today. That information is available publicly through RPHM media outlets and privately through word of mouth or via RPHM internal channels. However, regardless of the origin, that massive amount of RPHM data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of RPHM Old news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of RPHM Old relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to RPHM Old's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive RPHM Old alpha.

RPHM Old Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
RPHM Stock Earnings Reneo Pharmaceuticals Misses EPS for Q2 2024
08/13/2024
2
Acquisition by Leonard Braden Michael of 100487 shares of Reneo Pharmaceuticals at 1.4132 subject to Rule 16b-3
08/14/2024
3
RPHM Stock Alert Halper Sadeh LLC Is Investigating Whether the Merger of Reneo Pharmaceuticals, Inc. Is Fair to Shareholders
09/03/2024
4
Acquisition by Leonard Braden Michael of 172747 shares of Reneo Pharmaceuticals at 1.3712 subject to Rule 16b-3
09/16/2024
5
Reneo Pharmaceuticals executive buys over 76k in company stock
09/19/2024
6
Acquisition by Leonard Braden Michael of 68746 shares of Reneo Pharmaceuticals at 1.4964 subject to Rule 16b-3
09/25/2024
7
Reneo Pharmaceuticals Announces Stockholder Approval of Merger with OnKure
10/03/2024
8
OnKure Announces Closing of Merger with Reneo Pharmaceuticals and Concurrent Private Placement of 65 Million
10/04/2024
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Consideration for investing in RPHM Stock

If you are still planning to invest in RPHM Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the RPHM Old's history and understand the potential risks before investing.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Transaction History
View history of all your transactions and understand their impact on performance
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Content Syndication
Quickly integrate customizable finance content to your own investment portal